METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research

[1]  D. Norris,et al.  Structural network efficiency predicts conversion to dementia , 2016, Neurology.

[2]  V. Hachinski.  Correction. World Stroke Organization. Stroke and potentially preventable dementias proclamation: updated World Stroke Day proclamation. , 2016, Stroke.

[3]  A. Bronstein,et al.  Are white matter abnormalities associated with “unexplained dizziness”? , 2015, Journal of the Neurological Sciences.

[4]  V. Hachinski.  Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.

[5]  M. Mesulam,et al.  The Special Topics Section of Alzheimer's & Dementia , 2015, Alzheimer's & Dementia.

[6]  S. Pendlebury,et al.  Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (III) Applicability of Cognitive Tests , 2015, Stroke.

[7]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[8]  S. Pendlebury,et al.  Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (II) Effect of Attrition on Follow-Up , 2015, Stroke.

[9]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[10]  R. Righart,et al.  Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts , 2015, Neurology.

[11]  Richard Beare,et al.  Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[13]  David G. Norris,et al.  Relationship Between White Matter Hyperintensities, Cortical Thickness, and Cognition , 2015, Stroke.

[14]  N. Kandiah,et al.  Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease , 2015, European journal of neurology.

[15]  W. M. van der Flier,et al.  The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results , 2014, BMC Neurology.

[16]  David C. Anderson,et al.  Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial , 2014, The Lancet Neurology.

[17]  R. Akinyemi,et al.  Profile and determinants of vascular cognitive impairment in African stroke survivors: The CogFAST Nigeria Study , 2014, Journal of the Neurological Sciences.

[18]  L. Pantoni,et al.  Use of Montreal Cognitive Assessment in Patients With Stroke , 2014, Stroke.

[19]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[20]  A. W. Chung,et al.  Structural network efficiency is associated with cognitive impairment in small-vessel disease , 2014, Neurology.

[21]  Kenneth Rockwood,et al.  Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement , 2014, Alzheimer disease and associated disorders.

[22]  J. Zihl,et al.  Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments , 2013, Front. Aging Neurosci..

[23]  V. Feigin,et al.  Program for the Epidemiological Evaluation of Stroke in Tandil, Argentina (PREVISTA) Study: Rationale and Design , 2013, International journal of stroke : official journal of the International Stroke Society.

[24]  Nick C. Fox,et al.  Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls , 2013, Neurobiology of Aging.

[25]  Thaddeus J. Haight,et al.  Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. , 2013, JAMA neurology.

[26]  Bastiaan R. Bloem,et al.  Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60–97 Years: A Population-Based Study , 2013, PloS one.

[27]  Kaarin J Anstey,et al.  COSMIC (Cohort Studies of Memory in an International Consortium): An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups , 2013, Alzheimer's & Dementia.

[28]  P. Scheltens,et al.  Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients , 2013, PloS one.

[29]  R. Righart,et al.  Incident subcortical infarcts induce focal thinning in connected cortical regions , 2012, Neurology.

[30]  K. D. de Laat,et al.  Cerebral White Matter Lesions and Lacunar Infarcts Contribute to the Presence of Mild Parkinsonian Signs , 2012, Stroke.

[31]  W. Jagust,et al.  Vascular burden and Alzheimer disease pathologic progression , 2012, Neurology.

[32]  J. Wardlaw,et al.  Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Jennifer K. Harrison,et al.  Cognitive and Mood Assessment in Stroke Research: Focused Review of Contemporary Studies , 2012, Stroke.

[34]  Jeruza L Neyeloff,et al.  Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis , 2012, BMC Research Notes.

[35]  S. Leurgans,et al.  Cerebrovascular Disease Pathology and Parkinsonian Signs in Old Age , 2011, Stroke.

[36]  A. Lee,et al.  Vascular Dementia , 2011, Chonnam medical journal.

[37]  P. Nederkoorn,et al.  Aspirin in Alzheimer's Disease: Increased Risk of Intracerebral Hemorrhage: Cause for Concern? , 2010, Stroke.

[38]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[39]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[40]  S. Pendlebury.  Stroke-related dementia: rates, risk factors and implications for future research. , 2009, Maturitas.

[41]  S. Pendlebury,et al.  Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.

[42]  Frederik Barkhof,et al.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort , 2009, BMJ : British Medical Journal.

[43]  S. Pocock,et al.  Use of Ordinal Outcomes in Vascular Prevention Trials: Comparison With Binary Outcomes in Published Trials , 2008, Stroke.

[44]  V. Hachinski.  World Stroke Day 2008: "little strokes, big trouble". , 2008, Stroke.

[45]  P. Scheltens,et al.  Association of gait and balance disorders with age-related white matter changes , 2008, Neurology.

[46]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[47]  V. Hachinski.  The 2005 Thomas Willis Lecture: Stroke and Vascular Cognitive Impairment: A Transdisciplinary, Translational and Transactional Approach , 2007, Stroke.

[48]  B. Bloem,et al.  Neurological gait disorders in elderly people: clinical approach and classification , 2007, The Lancet Neurology.

[49]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[50]  R. Lipton,et al.  Epidemiology of Gait Disorders in Community‐Residing Older Adults , 2006, Journal of the American Geriatrics Society.

[51]  H. C. Chui,et al.  White matter lesions impair frontal lobe function regardless of their location , 2004, Neurology.

[52]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[53]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[54]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[55]  L A Beckett,et al.  Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.

[56]  J. Garcìa,et al.  The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. , 1995, Stroke.

[57]  V. Hachinski.  Vascular dementia: a radical redefinition. , 1994, Dementia.

[58]  D B Hier,et al.  Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. , 1990, Stroke.

[59]  J. Rankin.  Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.

[60]  GuidoChiti,et al.  Use of Montreal Cognitive Assessment in Patients With Stroke , 2014 .

[61]  J. Lodder.  Poststroke cognition and the fight against the hard problem: vascular neurologists, enter the arena! , 2007, Stroke.